Skip to main content
Elsevier

Nanocarriers in Prostate Cancer

Advanced Diagnosis and Treatment Strategies

  • 1st Edition - November 17, 2025
  • Latest edition
  • Editors: Bhupendra G. Prajapati, Devesh U. Kapoor, Nemat Ali, Anand Krishnan
  • Language: English

Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prosta… Read more

Description

Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prostate cancer therapy. Sections delve into different types of nanomaterials, including polymeric nanoparticles, DNA origami nanocarriers, and dendrimers. Each chapter explores their unique applications in targeted drug delivery, imaging, and therapeutic strategies, providing detailed insights into how nanotechnology revolutionizes prostate cancer care. This book benefits researchers, clinicians, and students focused on oncology and nanomedicine by offering a deep dive into the potential of nanocarriers in prostate cancer treatment.

This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies.

Key features

  • Provides in-depth coverage of nanocarrier types, showcasing their specific roles in prostate cancer treatment
  • Integrates the latest research findings with practical clinical applications
  • Offers valuable insights and practical examples that help advance understanding and application of nanotechnology in prostate cancer therapy

Readership

Medical Researchers, Oncologist, postgraduate students in cancer research, particularly those focusing on prostate cancer and the application of nanotechnology in oncology

Table of contents

1. Introduction

2. Polymeric Nanoparticles: Advancing Prostate Cancer Treatment

3. Advances in silica-based nanoparticles for targeting prostate cancer

4. Breakthrough in magnetic nanoparticles for management of prostate cancer

5. Innovative approaches of metallic (gold, silver) nanoparticles in targeting of prostate cancer

6. Recent application of liposomes, niosomes and exosomes in precise targeting of prostate cancer

7. Therapeutic Potential of Dendrimers in Prostate Cancer: Advances and Challenges

8. Carbon Nanotubes in Prostate Cancer: Emerging Frontiers in Diagnosis and Therapy

9. Targeted therapy of quantum dots against prostate cancer

10. Nanoemulsions and Nanosuspensions: Innovative Nanocarrier Systems for Prostate Cancer Management

11. Nanogels in Prostate Cancer: A Novel Avenue for Targeted Therapy and Enhanced Drug Delivery

12. DNA Origami Nanocarriers: Revolutionizing Prostate Cancer Therapy

Product details

  • Edition: 1
  • Latest edition
  • Published: November 17, 2025
  • Language: English

About the editors

BP

Bhupendra G. Prajapati

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.

Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India

DK

Devesh U. Kapoor

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.

Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India

NA

Nemat Ali

Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.

Affiliations and expertise
King Saud University, Saudi Arabia

AK

Anand Krishnan

Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.

Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

View book on ScienceDirect

Read Nanocarriers in Prostate Cancer on ScienceDirect